Mugnai G, Lewandowska K, Choi H U, Rosenberg L C, Culp L A
Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106.
Exp Cell Res. 1988 Apr;175(2):229-47. doi: 10.1016/0014-4827(88)90189-9.
Human neuroblastoma cells (Platt and La-N1) adhere and extend neurites on a ganglioside GM1-binding substratum provided by cholera toxin B (CTB). These adhesive responses, similar to those on plasma fibronectin (pFN), require the mediation of one or more cell-surface proteins [G. Mugnai and L. A. Culp (1987) Exp. Cell Res. 169, 328]. The involvement of two pFN receptor molecules in ganglioside GM1-mediated responses on CTB have now been tested. In order to test the role of cellular FN binding to its glycoprotein receptor integrin, a soluble peptide containing the Arg-Gly-Asp-Ser (RGDS) sequence was added to the medium. It did not inhibit attachment on CTB but completely inhibited formation of neurites; in contrast, the RGDS peptide minimally inhibited attachment or neurite formation on pFN. Once formed, neurites on CTB became resistant to the peptide. In order to test the role of cell-surface heparan sulfate proteoglycan (HS-PG), two approaches were used. First, the HS-binding protein platelet factor-4 (PF4) was used to dilute CTB or pFN on the substratum or, alternatively, added to the medium. Diluting the substratum ligand with PF4 had no effects on attachment on either CTB or pFN. However, neurite formation on CTB was readily inhibited and on pFN partially inhibited; the effects of PF4 were far greater than a similar dilution with nonbinding albumin. When PF4 was added to the medium of cells, attachment on either substratum was unaffected as was neurite outgrowth on pFN, revealing differences in PF4's inhibition as the substratum-bound or medium-borne component. In contrast, PF4 in the medium at low concentrations (1 microgram/ml) was highly inhibitory for neurite formation on CTB. The second approach utilized the addition of bovine cartilage dermatan sulfate proteoglycan (DS-PG), shown to bind to pFN as well as to substratum-bound CTB by ELISA, or cartilage chondroitin sulfate/keratan sulfate proteoglycan (CS/KS-PG) to the substratum or to the medium. At low concentrations, DS-PG but not CS/KS-PG actually stimulated neurite formation on CTB while at higher concentrations DS-PG completely inhibited attachment and neurite formation. While DS-PG partially inhibited attachment on pFN, it had no effect on neurite formation of the attached cells. Neuroblastoma cells adhered to some extent to substrata coated only with DS-PG, indicating "receptors" for PGs that permit stable interaction.(ABSTRACT TRUNCATED AT 400 WORDS)
人神经母细胞瘤细胞(普拉特细胞和拉 - N1细胞)在霍乱毒素B(CTB)提供的神经节苷脂GM1结合基质上黏附并延伸神经突。这些黏附反应,类似于在血浆纤连蛋白(pFN)上的反应,需要一种或多种细胞表面蛋白的介导[G. 穆格纳伊和L. A. 卡尔普(1987年)《细胞实验研究》169卷,328页]。现在已经测试了两种pFN受体分子在CTB上神经节苷脂GM1介导反应中的作用。为了测试细胞FN与其糖蛋白受体整合素结合的作用,向培养基中添加了一种含有精氨酸 - 甘氨酸 - 天冬氨酸 - 丝氨酸(RGDS)序列的可溶性肽。它没有抑制在CTB上的黏附,但完全抑制了神经突的形成;相比之下,RGDS肽对在pFN上的黏附或神经突形成的抑制作用最小。一旦形成,CTB上的神经突对该肽产生抗性。为了测试细胞表面硫酸乙酰肝素蛋白聚糖(HS - PG)的作用,采用了两种方法。首先,使用HS结合蛋白血小板因子4(PF4)来稀释基质上的CTB或pFN,或者将其添加到培养基中。用PF4稀释基质配体对在CTB或pFN上的黏附没有影响。然而,CTB上的神经突形成很容易被抑制,而pFN上的神经突形成则部分被抑制;PF4的作用远大于用非结合性白蛋白进行类似稀释的效果。当PF4添加到细胞培养基中时,在任何一种基质上的黏附都不受影响,pFN上的神经突生长也不受影响,这揭示了PF4作为基质结合成分或培养基成分时抑制作用的差异。相比之下,培养基中低浓度(1微克/毫升)的PF4对CTB上的神经突形成具有高度抑制作用。第二种方法是向基质或培养基中添加牛软骨硫酸皮肤素蛋白聚糖(DS - PG),通过酶联免疫吸附测定法显示其能与pFN以及基质结合的CTB结合,或者添加软骨硫酸软骨素/硫酸角质素蛋白聚糖(CS/KS - PG)。在低浓度下,DS - PG而非CS/KS - PG实际上刺激了CTB上的神经突形成,而在较高浓度下,DS - PG完全抑制黏附和神经突形成。虽然DS - PG部分抑制了在pFN上的黏附,但对已黏附细胞的神经突形成没有影响。神经母细胞瘤细胞在一定程度上黏附于仅涂有DS - PG的基质上,表明存在允许稳定相互作用的PG“受体”。(摘要截取自400字)